blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3368658

EP3368658 - EXPANSION OF NON-HAEMATOPOIETIC TISSUE-RESIDENT GAMMA DELTA T CELLS AND USES OF THESE CELLS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  12.05.2023
Database last updated on 18.11.2024
FormerThe patent has been granted
Status updated on  03.06.2022
FormerGrant of patent is intended
Status updated on  16.01.2022
FormerExamination is in progress
Status updated on  12.06.2019
FormerRequest for examination was made
Status updated on  03.08.2018
FormerThe international publication has been made
Status updated on  05.05.2017
Formerunknown
Status updated on  09.11.2016
Most recent event   Tooltip13.09.2024Lapse of the patent in a contracting state
New state(s): MT		published on 16.10.2024  [2024/42]
Applicant(s)For all designated states
Cancer Research Technology Limited
2 Redman Place
London E20 1JQ / GB
For all designated states
King's College London
The Strand
London, Greater London WC2R 2LS / GB
For all designated states
The Francis Crick Institute Limited
1 Midland Road
London, Greater London NW1 1AT / GB
[2022/25]
Former [2018/36]For all designated states
Cancer Research Technology Limited
Angel Building
407 St. John Street
London, Greater London EC1V 4AD / GB
For all designated states
King's College London
The Strand
London, Greater London WC2R 2LS / GB
For all designated states
The Francis Crick Institute Limited
1 Midland Road
London, Greater London NW1 1AT / GB
Inventor(s)01 / HAYDAY, Adrian
King's College London School of Medicine
2nd Floor Borough Wing
London Greater London SE1 9RT / GB
02 / NUSSBAUMER, Oliver
King's College London School of Medicine
2nd Floor Borough Wing
London Greater London SE1 9RT / GB
03 / WOOLF, Richard
King's College London School of Medicine
2nd Floor Borough Wing
London Greater London SE1 9RT / GB
 [2018/36]
Representative(s)Mewburn Ellis LLP
Aurora Building
Counterslip
Bristol BS1 6BX / GB
[2022/27]
Former [2018/36]Hayes, Emily Anne Luxford, et al
Mewburn Ellis LLP
City Tower
40 Basinghall Street
London EC2V 5DE / GB
Application number, filing date16788539.131.10.2016
[2018/36]
WO2016EP76264
Priority number, dateGB2015001919830.10.2015         Original published format: GB 201519198
GB2016001273122.07.2016         Original published format: GB 201612731
[2018/36]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2017072367
Date:04.05.2017
Language:EN
[2017/18]
Type: A1 Application with search report 
No.:EP3368658
Date:05.09.2018
Language:EN
The application published by WIPO in one of the EPO official languages on 04.05.2017 takes the place of the publication of the European patent application.
[2018/36]
Type: B1 Patent specification 
No.:EP3368658
Date:06.07.2022
Language:EN
[2022/27]
Search report(s)International search report - published on:EP04.05.2017
ClassificationIPC:C12N5/0783
[2018/36]
CPC:
C12N5/0638 (EP,IL,KR,US); A61K39/4611 (EP,KR,US); A61K39/4644 (EP,KR,US);
A61P31/12 (EP,IL); A61P31/18 (EP,IL,KR); A61P31/22 (EP,IL);
A61P35/00 (EP,IL,KR); G01N33/505 (KR); C12N2501/2302 (EP,IL,KR,US);
C12N2501/2315 (EP,IL,KR,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2018/36]
Extension statesBA24.05.2018
ME24.05.2018
Validation statesMANot yet paid
MDNot yet paid
TitleGerman:EXPANSION VON NICHT-HAEMATOPOIETISCHEN GEWEBERESIDENTEN GAMMA-DELTA-T-ZELLEN UND VERWENDUNG DIESER ZELLEN[2018/36]
English:EXPANSION OF NON-HAEMATOPOIETIC TISSUE-RESIDENT GAMMA DELTA T CELLS AND USES OF THESE CELLS[2018/36]
French:MULTIPLICATION DE CELLULES T GAMMA DELTA RÉSIDENTES DES TISSUS NON HÉMATOPOÏÉTIQUES ET UTILISATIONS DE CES CELLULES[2018/36]
Entry into regional phase24.05.2018National basic fee paid 
24.05.2018Designation fee(s) paid 
24.05.2018Examination fee paid 
Examination procedure24.05.2018Examination requested  [2018/36]
24.05.2018Date on which the examining division has become responsible
21.12.2018Amendment by applicant (claims and/or description)
21.06.2019Despatch of a communication from the examining division (Time limit: M06)
19.12.2019Reply to a communication from the examining division
24.02.2020Despatch of a communication from the examining division (Time limit: M06)
29.09.2020Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
07.12.2020Reply to a communication from the examining division
17.01.2022Communication of intention to grant the patent
24.05.2022Fee for grant paid
24.05.2022Fee for publishing/printing paid
24.05.2022Receipt of the translation of the claim(s)
Divisional application(s)EP22182997.1  / EP4148124
Opposition(s)11.04.2023No opposition filed within time limit [2023/24]
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the examination report
07.12.2020Request for further processing filed
07.12.2020Full payment received (date of receipt of payment)
Request granted
16.12.2020Decision despatched
Fees paidRenewal fee
24.05.2018Renewal fee patent year 03
22.10.2019Renewal fee patent year 04
14.10.2020Renewal fee patent year 05
09.09.2021Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU31.10.2016
AL06.07.2022
BG06.07.2022
CY06.07.2022
EE06.07.2022
HR06.07.2022
LT06.07.2022
LV06.07.2022
MC06.07.2022
MK06.07.2022
MT06.07.2022
RO06.07.2022
RS06.07.2022
SI06.07.2022
SK06.07.2022
SM06.07.2022
LU31.10.2022
IS06.11.2022
[2024/42]
Former [2024/34]HU31.10.2016
AL06.07.2022
BG06.07.2022
CY06.07.2022
EE06.07.2022
HR06.07.2022
LT06.07.2022
LV06.07.2022
MC06.07.2022
MK06.07.2022
RO06.07.2022
RS06.07.2022
SI06.07.2022
SK06.07.2022
SM06.07.2022
LU31.10.2022
IS06.11.2022
Former [2024/27]HU31.10.2016
AL06.07.2022
CY06.07.2022
EE06.07.2022
HR06.07.2022
LT06.07.2022
LV06.07.2022
MC06.07.2022
MK06.07.2022
RO06.07.2022
RS06.07.2022
SI06.07.2022
SK06.07.2022
SM06.07.2022
LU31.10.2022
IS06.11.2022
Former [2024/21]HU31.10.2016
AL06.07.2022
CY06.07.2022
EE06.07.2022
HR06.07.2022
LT06.07.2022
LV06.07.2022
MC06.07.2022
RO06.07.2022
RS06.07.2022
SI06.07.2022
SK06.07.2022
SM06.07.2022
LU31.10.2022
IS06.11.2022
Former [2024/18]HU31.10.2016
AL06.07.2022
EE06.07.2022
HR06.07.2022
LT06.07.2022
LV06.07.2022
MC06.07.2022
RO06.07.2022
RS06.07.2022
SI06.07.2022
SK06.07.2022
SM06.07.2022
LU31.10.2022
IS06.11.2022
Former [2023/37]AL06.07.2022
EE06.07.2022
HR06.07.2022
LT06.07.2022
LV06.07.2022
MC06.07.2022
RO06.07.2022
RS06.07.2022
SI06.07.2022
SK06.07.2022
SM06.07.2022
LU31.10.2022
IS06.11.2022
Former [2023/30]AL06.07.2022
EE06.07.2022
HR06.07.2022
LT06.07.2022
LV06.07.2022
MC06.07.2022
RO06.07.2022
RS06.07.2022
SK06.07.2022
SM06.07.2022
LU31.10.2022
IS06.11.2022
Former [2023/29]AL06.07.2022
EE06.07.2022
HR06.07.2022
LT06.07.2022
LV06.07.2022
MC06.07.2022
RO06.07.2022
RS06.07.2022
SK06.07.2022
SM06.07.2022
IS06.11.2022
Former [2023/25]EE06.07.2022
HR06.07.2022
LT06.07.2022
LV06.07.2022
MC06.07.2022
RO06.07.2022
RS06.07.2022
SK06.07.2022
SM06.07.2022
IS06.11.2022
Former [2023/23]EE06.07.2022
HR06.07.2022
LT06.07.2022
LV06.07.2022
RO06.07.2022
RS06.07.2022
SK06.07.2022
SM06.07.2022
IS06.11.2022
Former [2023/22]HR06.07.2022
LT06.07.2022
LV06.07.2022
RO06.07.2022
RS06.07.2022
SM06.07.2022
IS06.11.2022
Former [2023/20]HR06.07.2022
LT06.07.2022
LV06.07.2022
RS06.07.2022
SM06.07.2022
IS06.11.2022
Former [2023/12]HR06.07.2022
LT06.07.2022
LV06.07.2022
RS06.07.2022
IS06.11.2022
Former [2023/10]HR06.07.2022
LT06.07.2022
LV06.07.2022
RS06.07.2022
Former [2023/09]LT06.07.2022
LV06.07.2022
RS06.07.2022
Former [2023/08]LT06.07.2022
RS06.07.2022
Cited inInternational search[E]WO2016198480  (LYMPHACT - LYMPHOCYTE ACTIVATION TECH S A [PT]);
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.